L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.
Saved in:
| Title: | L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial. |
|---|---|
| Authors: | Nematizadeh M; Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran., Ghorbanzadeh H; Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran., Moghaddam HS; Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran., Shalbafan M; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Boroon M; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Keshavarz-Akhlaghi AA; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Akhondzadeh S; Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran. |
| Source: | Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2023 Sep; Vol. 77 (9), pp. 478-485. Date of Electronic Publication: 2023 May 27. |
| Publication Type: | Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9513551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1819 (Electronic) Linking ISSN: 13231316 NLM ISO Abbreviation: Psychiatry Clin Neurosci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37169515 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nematizadeh+M%22">Nematizadeh M</searchLink>; Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Ghorbanzadeh+H%22">Ghorbanzadeh H</searchLink>; Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Moghaddam+HS%22">Moghaddam HS</searchLink>; Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Shalbafan+M%22">Shalbafan M</searchLink>; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Boroon+M%22">Boroon M</searchLink>; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Keshavarz-Akhlaghi+AA%22">Keshavarz-Akhlaghi AA</searchLink>; Mental Health Research Center, Psychosocial Health Research Institute (PHRI), Department of Psychiatry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Akhondzadeh+S%22">Akhondzadeh S</searchLink>; Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229513551%22">Psychiatry and clinical neurosciences</searchLink> [Psychiatry Clin Neurosci] 2023 Sep; Vol. 77 (9), pp. 478-485. <i>Date of Electronic Publication: </i>2023 May 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Science%22">Blackwell Science </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>9513551 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1440-1819 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213231316%22">13231316 </searchLink><i>NLM ISO Abbreviation: </i>Psychiatry Clin Neurosci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37169515 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/pcn.13565 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 478 Titles: – TitleFull: L-theanine combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nematizadeh M – PersonEntity: Name: NameFull: Ghorbanzadeh H – PersonEntity: Name: NameFull: Moghaddam HS – PersonEntity: Name: NameFull: Shalbafan M – PersonEntity: Name: NameFull: Boroon M – PersonEntity: Name: NameFull: Keshavarz-Akhlaghi AA – PersonEntity: Name: NameFull: Akhondzadeh S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1440-1819 Numbering: – Type: volume Value: 77 – Type: issue Value: 9 Titles: – TitleFull: Psychiatry and clinical neurosciences Type: main |
| ResultId | 1 |
